Volenrelaxin
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Volenrelaxin (LY3540378) is a long-acting, synthetic analogue of relaxin developed by Eli Lilly and Company to treat heart failure.[1][2]
| Clinical data | |
|---|---|
| Other names | LY3540378 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| UNII | |
| KEGG | |
